is a topic covered in the Johns Hopkins Diabetes Guide
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
- Bromoctriptine quick-release (QR) approved in 2009 for type 2 diabetes mellitus, as an adjunct to diet and exercise
- Other FDA indications include: prolactin-secreting adenomas, hyperprolactinemia, acromegaly, Parkinson’s disease
- Neuroleptic malignant syndrome
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: June 2, 2019
Crowder, Alona, and Aniket Sidhaye. "Bromocriptine." Johns Hopkins Diabetes Guide, 2019. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/6/Bromocriptine.
Crowder A, Sidhaye A. Bromocriptine. Johns Hopkins Diabetes Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/6/Bromocriptine. Accessed December 12, 2019.
Crowder, A., & Sidhaye, A. (2019). Bromocriptine. In Johns Hopkins Diabetes Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/6/Bromocriptine
Crowder A, Sidhaye A. Bromocriptine [Internet]. In: Johns Hopkins Diabetes Guide. ; 2019. [cited 2019 December 12]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/6/Bromocriptine.
TY - ELEC
T1 - Bromocriptine
ID - 547171
A1 - Crowder,Alona,PharmD
AU - Sidhaye,Aniket,M.D.
Y1 - 2019/06/02/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547171/6/Bromocriptine
DB - Johns Hopkins Guide
DP - Unbound Medicine